-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Vitro Biopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from Q2 2010 to Q2 2025.
- Vitro Biopharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Jul 2025 was 4.46M shares, unchanged year-over-year.
- Vitro Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 4.46M shares, a 0.65% increase from 2023.
- Vitro Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 4.43M shares, a 6.91% increase from 2022.
- Vitro Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 4.14M shares.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)